CEP85

Across TCGA pan-cancer cohorts, CEP85 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CEP85’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where CEP85 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CEP85 is over-expressed in tumor, although a few such as OV show the opposite, repressed pattern.

LUAD and OV are the cancer types where CEP85 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEP85 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.166	<.001	4	view →
OV	All	All	−0.744	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CEP85–LUAD

Open the LUAD breakdown →